BR0306820A - Uso de inibidores cox-2 em combinação com agentes antivirais para o tratamento de infecções de papilomavìrus - Google Patents
Uso de inibidores cox-2 em combinação com agentes antivirais para o tratamento de infecções de papilomavìrusInfo
- Publication number
- BR0306820A BR0306820A BR0306820-0A BR0306820A BR0306820A BR 0306820 A BR0306820 A BR 0306820A BR 0306820 A BR0306820 A BR 0306820A BR 0306820 A BR0306820 A BR 0306820A
- Authority
- BR
- Brazil
- Prior art keywords
- cox
- inhibitors
- treatment
- combination
- antiviral agents
- Prior art date
Links
- 229940111134 coxibs Drugs 0.000 title abstract 2
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 title abstract 2
- 208000009608 Papillomavirus Infections Diseases 0.000 title 1
- 239000003443 antiviral agent Substances 0.000 title 1
- 241001631646 Papillomaviridae Species 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
- H01L21/02—Manufacture or treatment of semiconductor devices or of parts thereof
- H01L21/027—Making masks on semiconductor bodies for further photolithographic processing not provided for in group H01L21/18 or H01L21/34
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Rheumatology (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Computer Hardware Design (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Power Engineering (AREA)
- Pain & Pain Management (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"USO DE INIBIDORES COX-2 EM COMBINAçãO COM AGENTES ANTIVIRAIS PARA O TRATAMENTO DE INFECçõES DE PAPILOMAVìRUS". A presente invenção refere-se a terapias combinadas para tratar o papilomavírus.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34755002P | 2002-01-10 | 2002-01-10 | |
PCT/US2003/000016 WO2003059347A1 (en) | 2002-01-10 | 2003-01-10 | Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0306820A true BR0306820A (pt) | 2004-12-07 |
Family
ID=23364195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0306820-0A BR0306820A (pt) | 2002-01-10 | 2003-01-10 | Uso de inibidores cox-2 em combinação com agentes antivirais para o tratamento de infecções de papilomavìrus |
Country Status (16)
Country | Link |
---|---|
US (1) | US20030211163A1 (pt) |
EP (1) | EP1463500A1 (pt) |
JP (1) | JP2005519061A (pt) |
KR (1) | KR20040072720A (pt) |
CN (1) | CN1697654A (pt) |
AU (1) | AU2003201811A1 (pt) |
BR (1) | BR0306820A (pt) |
CA (1) | CA2472459A1 (pt) |
CO (1) | CO5590913A2 (pt) |
IL (1) | IL162726A0 (pt) |
MX (1) | MXPA04006572A (pt) |
NO (1) | NO20043313L (pt) |
PL (1) | PL371252A1 (pt) |
RU (1) | RU2004121147A (pt) |
WO (1) | WO2003059347A1 (pt) |
ZA (1) | ZA200404881B (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001014570A1 (en) | 1999-08-25 | 2001-03-01 | Allergan Sales, Inc. | Activatable recombinant neurotoxins |
US7740868B2 (en) | 1999-08-25 | 2010-06-22 | Allergan, Inc. | Activatable clostridial toxins |
US20040152752A1 (en) * | 2002-05-30 | 2004-08-05 | Chong Kong Teck | Treatment for human papillomavirus |
CN1726018A (zh) * | 2002-12-19 | 2006-01-25 | 法玛西雅公司 | 使用环加氧酶-2选择性抑制剂或环加氧酶-2抑制剂联合抗病毒剂治疗疱疹病毒感染的方法和组合物 |
US8940755B2 (en) | 2003-12-02 | 2015-01-27 | 3M Innovative Properties Company | Therapeutic combinations and methods including IRM compounds |
US20100009928A1 (en) | 2004-03-29 | 2010-01-14 | Cheng Jin Q | Compositions including triciribine and taxanes and methods of use thereof |
US8080560B2 (en) | 2004-12-17 | 2011-12-20 | 3M Innovative Properties Company | Immune response modifier formulations containing oleic acid and methods |
PE20061303A1 (es) * | 2005-03-30 | 2006-12-07 | Astion Dev As | Composicion farmaceutica que comprende oxaprozina |
CA2609303A1 (en) * | 2005-05-18 | 2006-11-23 | Alt Solutions, Inc. | Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer |
KR100644968B1 (ko) * | 2005-10-28 | 2006-11-14 | 한국과학기술연구원 | 생체적합성 실리콘 나노입자의 제조 방법 |
WO2008036858A2 (en) | 2006-09-20 | 2008-03-27 | The Board Of Regents Of The University Of Texas System | Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief |
ITRM20080027A1 (it) * | 2008-01-18 | 2009-07-19 | Maria Balestrieri | Uso di aciclovir per il trattamento delle condilomatosi. |
EP3581169A1 (en) | 2008-01-22 | 2019-12-18 | The Board Of Regents Of The University Of Texas System | Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief |
EP2276464A2 (en) * | 2008-04-15 | 2011-01-26 | Mallinckrodt Inc. | Combinations of antiviral agents and other compounds |
IL192335A0 (en) * | 2008-06-19 | 2011-08-01 | Avivi Easy Life Ltd | Antiviral compounds |
US20110218241A1 (en) * | 2010-03-06 | 2011-09-08 | Cacao Bio-Technologies, Llc | Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts |
JP2012020991A (ja) * | 2010-06-16 | 2012-02-02 | Takasago Internatl Corp | 経皮吸収促進剤、及びこれを含有する皮膚外用製剤 |
US9642824B2 (en) * | 2012-02-06 | 2017-05-09 | Innovative Med Concepts, LLC | Valaciclovir and diclofenac combination therapy for functional somatic syndromes |
TWI646091B (zh) * | 2012-12-28 | 2019-01-01 | 日商衛斯克慧特股份有限公司 | 鹽類及晶形 |
WO2016036588A1 (en) * | 2014-09-03 | 2016-03-10 | Merck Sharp & Dohme Corp. | Pharmaceutical suspensions containing etoricoxib |
CN105906496A (zh) * | 2016-05-16 | 2016-08-31 | 苏州毕诺佳医药技术有限公司 | 一种阿昔洛韦的药物组合物及其医药用途 |
CN114423423B (zh) * | 2020-12-28 | 2022-09-06 | 中以海德人工智能药物研发股份有限公司 | 一种用于治疗或预防病毒性肝炎的药物组合物及其应用 |
EP4340884A1 (en) * | 2021-05-19 | 2024-03-27 | University of Miami | Treatment of infections in and around the eye |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6114314A (en) * | 1992-02-21 | 2000-09-05 | Hyal Pharmaceutical Corp. | Formulations containing hyaluronic acid |
US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
US5633272A (en) * | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
US6180651B1 (en) * | 1996-04-04 | 2001-01-30 | Bristol-Myers Squibb | Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics |
PL195955B1 (pl) * | 1996-04-12 | 2007-11-30 | Searle & Co | Związek, pochodna benzenosulfonamidu, sposób jegowytwarzania, kompozycja farmaceutyczna zawierająca go oraz jego zastosowanie |
GB9615867D0 (en) * | 1996-07-03 | 1996-09-11 | Merck & Co Inc | Process of preparing phenyl heterocycles useful as cox-2 inhibitors |
US6034256A (en) * | 1997-04-21 | 2000-03-07 | G.D. Searle & Co. | Substituted benzopyran derivatives for the treatment of inflammation |
US6077850A (en) * | 1997-04-21 | 2000-06-20 | G.D. Searle & Co. | Substituted benzopyran analogs for the treatment of inflammation |
CA2313049A1 (en) * | 1997-12-17 | 1999-06-24 | Cornell Research Foundation, Inc. | Cyclooxygenase-2 inhibition |
EP1202620A1 (en) * | 1999-05-14 | 2002-05-08 | The Regents of the University of California | Anti-inflammatory therapy for inflammatory mediated infection |
US20030004142A1 (en) * | 2001-04-18 | 2003-01-02 | Prior Christopher P. | Use of NSAIDs for prevention and treatment of cellular abnormalities of the lung or bronchial pathway |
US20030004143A1 (en) * | 2001-04-18 | 2003-01-02 | Prior Christopher P. | Use of NSAIDs for prevention and treatment of cellular abnormalities of the female reproductive tract |
-
2003
- 2003-01-10 KR KR10-2004-7010785A patent/KR20040072720A/ko not_active Application Discontinuation
- 2003-01-10 JP JP2003559509A patent/JP2005519061A/ja active Pending
- 2003-01-10 WO PCT/US2003/000016 patent/WO2003059347A1/en not_active Application Discontinuation
- 2003-01-10 US US10/339,906 patent/US20030211163A1/en not_active Abandoned
- 2003-01-10 BR BR0306820-0A patent/BR0306820A/pt not_active IP Right Cessation
- 2003-01-10 RU RU2004121147/14A patent/RU2004121147A/ru not_active Application Discontinuation
- 2003-01-10 IL IL16272603A patent/IL162726A0/xx unknown
- 2003-01-10 MX MXPA04006572A patent/MXPA04006572A/es not_active Application Discontinuation
- 2003-01-10 PL PL03371252A patent/PL371252A1/xx not_active Application Discontinuation
- 2003-01-10 EP EP03700670A patent/EP1463500A1/en not_active Withdrawn
- 2003-01-10 CA CA002472459A patent/CA2472459A1/en not_active Abandoned
- 2003-01-10 CN CNA038057212A patent/CN1697654A/zh active Pending
- 2003-01-10 AU AU2003201811A patent/AU2003201811A1/en not_active Abandoned
-
2004
- 2004-06-21 ZA ZA200404881A patent/ZA200404881B/en unknown
- 2004-07-08 CO CO04064572A patent/CO5590913A2/es not_active Application Discontinuation
- 2004-11-04 NO NO20043313A patent/NO20043313L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20040072720A (ko) | 2004-08-18 |
ZA200404881B (en) | 2005-08-31 |
NO20043313L (no) | 2004-10-08 |
US20030211163A1 (en) | 2003-11-13 |
MXPA04006572A (es) | 2005-11-04 |
IL162726A0 (en) | 2005-11-20 |
PL371252A1 (en) | 2005-06-13 |
EP1463500A1 (en) | 2004-10-06 |
JP2005519061A (ja) | 2005-06-30 |
AU2003201811A1 (en) | 2003-07-30 |
CO5590913A2 (es) | 2005-12-30 |
RU2004121147A (ru) | 2005-04-10 |
CN1697654A (zh) | 2005-11-16 |
CA2472459A1 (en) | 2003-07-24 |
WO2003059347A1 (en) | 2003-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0306820A (pt) | Uso de inibidores cox-2 em combinação com agentes antivirais para o tratamento de infecções de papilomavìrus | |
TW200505434A (en) | Therapeutic treatment | |
MY143407A (en) | Indazole derivatives as inhibitors of hormone sensitive lipase | |
BR0314603A (pt) | Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos | |
BRPI0411900A (pt) | compostos antivirais e métodos | |
SG145699A1 (en) | Pyridazine derivatives and their use as therapeutic agents | |
TW200612918A (en) | Lonidamine analogs | |
IL158559A0 (en) | Acne treatment | |
MY138059A (en) | Use of ikb-kinase inhibitors in pain therapy | |
HK1124546A1 (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder | |
DE60112306D1 (de) | Kondensierte pyrazindionderivate als pde5 inhibitore | |
ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
HRP20090513T1 (en) | S-mirtazapine for the treatment of hot flush | |
BR0314844A (pt) | Novo composto | |
BR0314843A (pt) | Novo composto | |
ATE333457T1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
BR0317539A (pt) | Métodos e composições para o tratamento de infecções por vìrus da herpes usando inibidores seletivos da ou ciclooxigenase-2 ou inibidores da ciclooxigenase-2 em combinação com agentes antivirais | |
ATE410154T1 (de) | Pharmazeutische zusammensetzung enthaltend 2,4- dichlorbenzylalkohol und amylmetakresol | |
BR0012675A (pt) | Uso de inibidores de il-18 | |
DE60122559D1 (de) | Indolderivate als pde5-inhibitoren | |
BR0307085A (pt) | Terapia combinada para o tratamento de infecções bacterianas | |
ATE360422T1 (de) | Tetrazyklische verbindungen als pde5-inhibitoren | |
BR0002640A (pt) | Uso de simeticona para tratar colite ulcerativa | |
MY140194A (en) | Novel fusidic acid derivatives | |
MX2020002008A (es) | Tratamientos antivirales intravenosos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A, 7A, 8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2156 DE 02/05/2012. |